Form4insider filings, from the source

SEC Form 4 · accession 0000914190-19-000004

REGENERX BIOPHARMACEUTICALS INC · RGRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 6, 2019
Accepted (ET)
Jan 8, 2019 · 4:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000707511

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 6, 2019C522,280$0.06A6,524,122D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Convertible Promissory Note (right to buy)F1$0.06Jan 6, 2019C522,280DJan 7, 2014Jan 6, 2019Common Stock522,2800D
Stock Option (right to buy)F2$0.21holding————Mar 25, 2021Common Stock120,000120,000D
Stock Option (right to buy)F2$0.19holding————Feb 11, 2022Common Stock100,000100,000D
Stock Option (right to buy)F2$0.36holding————Jun 30, 2022Common Stock100,000100,000D
Stock Option (right to buy)F3$0.64holding————Mar 16, 2023Common Stock100,000100,000D
Stock Option (right to buy)F4$0.28holding————Sep 1, 2027Common Stock125,000125,000D
Stock Option (right to buy)F5$0.21holding————Jul 17, 2028Common Stock200,000200,000D

Explanation of responses